TRECARICHI, ENRICO MARIA
 Distribuzione geografica
Continente #
AS - Asia 2.372
SA - Sud America 1.270
NA - Nord America 487
EU - Europa 303
AF - Africa 77
Totale 4.509
Nazione #
BR - Brasile 997
SG - Singapore 693
VN - Vietnam 564
US - Stati Uniti d'America 400
CN - Cina 372
HK - Hong Kong 346
KR - Corea 196
DE - Germania 117
AR - Argentina 116
ID - Indonesia 67
EC - Ecuador 62
MX - Messico 62
IT - Italia 54
BD - Bangladesh 30
RU - Federazione Russa 30
ZA - Sudafrica 30
CO - Colombia 28
PY - Paraguay 27
FR - Francia 26
UA - Ucraina 22
CL - Cile 19
PL - Polonia 19
IN - India 18
PK - Pakistan 14
IQ - Iraq 12
TN - Tunisia 12
MA - Marocco 11
EG - Egitto 7
UY - Uruguay 7
UZ - Uzbekistan 7
CA - Canada 6
DO - Repubblica Dominicana 6
NL - Olanda 6
PE - Perù 6
VE - Venezuela 6
AL - Albania 5
AZ - Azerbaigian 5
JM - Giamaica 5
NP - Nepal 4
PH - Filippine 4
SA - Arabia Saudita 4
SE - Svezia 4
BG - Bulgaria 3
CY - Cipro 3
DZ - Algeria 3
ES - Italia 3
ET - Etiopia 3
GB - Regno Unito 3
KE - Kenya 3
LB - Libano 3
OM - Oman 3
TR - Turchia 3
TW - Taiwan 3
AM - Armenia 2
AO - Angola 2
AT - Austria 2
BH - Bahrain 2
BO - Bolivia 2
IE - Irlanda 2
JO - Giordania 2
JP - Giappone 2
KH - Cambogia 2
KW - Kuwait 2
MN - Mongolia 2
PA - Panama 2
SN - Senegal 2
AE - Emirati Arabi Uniti 1
AG - Antigua e Barbuda 1
BY - Bielorussia 1
CR - Costa Rica 1
GA - Gabon 1
GE - Georgia 1
GR - Grecia 1
GT - Guatemala 1
HN - Honduras 1
HR - Croazia 1
IL - Israele 1
IR - Iran 1
IS - Islanda 1
KZ - Kazakistan 1
LV - Lettonia 1
MD - Moldavia 1
MT - Malta 1
MY - Malesia 1
NG - Nigeria 1
PR - Porto Rico 1
RE - Reunion 1
RW - Ruanda 1
SV - El Salvador 1
TH - Thailandia 1
Totale 4.509
Città #
Hong Kong 346
Ho Chi Minh City 206
Seoul 196
Ashburn 151
Singapore 133
Hanoi 120
Frankfurt am Main 112
São Paulo 80
Beijing 71
San Jose 70
Dallas 56
Rio de Janeiro 37
Mexico City 35
Hillsboro 30
Haiphong 23
Thái Bình 23
Da Nang 20
Guayaquil 20
Quito 18
Warsaw 18
Campinas 16
Curitiba 16
Jakarta 16
New York 16
Ribeirão Preto 15
Biên Hòa 14
Manaus 14
Belo Horizonte 13
Brasília 13
Asunción 12
Guarulhos 12
Cape Town 11
Porto Alegre 11
Caxias do Sul 10
Goiânia 10
Hải Dương 10
Johannesburg 10
Ninh Bình 10
Salvador 10
Bắc Ninh 9
Juiz de Fora 9
Bogotá 8
Buenos Aires 8
Phủ Lý 8
Santo André 8
Thái Nguyên 8
Baghdad 7
Belém 7
Montevideo 7
São José do Rio Preto 7
Bologna 6
Can Tho 6
Fortaleza 6
Ha Long 6
Huế 6
Londrina 6
Los Angeles 6
Praia Grande 6
Santiago 6
Tashkent 6
Baku 5
Casablanca 5
Catanduva 5
Ciudad del Este 5
Contagem 5
La Plata 5
Lima 5
Lấp Vò 5
Maricá 5
Piracicaba 5
Recife 5
San Juan 5
St Petersburg 5
São Gonçalo 5
Tây Ninh 5
Viamão 5
Vila Velha 5
Bauru 4
Carapicuíba 4
Council Bluffs 4
Duque de Caxias 4
Formosa 4
Gravataí 4
Hưng Yên 4
Joinville 4
Limburg an der Lahn 4
Lomas de Zamora 4
Maceió 4
Moscow 4
Patos de Minas 4
Quảng Ngãi 4
Reston 4
Santos 4
Sumaré 4
Surabaya 4
São Bernardo do Campo 4
São Carlos 4
São José dos Campos 4
Tirana 4
Tunis 4
Totale 2.327
Nome #
(1,3)-beta-d-Glucan-based antifungal treatment in critically ill adults at high risk of candidaemia: an observational study 54
Biofilm production by Candida species and inadequate antifungal therapy as predictors of mortality for patients with candidemia 52
(1,3)-β-d-Glucan-based antifungal treatment in critically ill adults at high risk of candidaemia: an observational study 51
A Predictive Model of Mortality in Patients With Bloodstream Infections due to Carbapenemase-Producing Enterobacteriaceae 38
An autochthonous case of cutaneous bacillary angiomatosis not related to major immunosuppression: An emerging or overlooked disease? 38
Identification of pmrB mutations as putative mechanism for colistin resistance in A. baumannii strains isolated after in vivo colistin exposure 37
Bacterial Ventilator-Associated Pneumonia in COVID-19 Patients: Data from the Second and Third Waves of the Pandemic 36
Risk factors for the development of hospital-acquired pneumonia in patients with carbapenem-resistant Acinetobacter baumannii respiratory colonization and the role of multisite colonization: a multicenter retrospective study 36
Costs of Bloodstream Infections Caused by Escherichia coli and Influence of Extended-Spectrum-beta-Lactamase Production and Inadequate Initial Antibiotic Therapy 36
Outcome of hbv screening and vaccination in a migrant population in southern italy 35
Multidrug-resistant Pseudomonas aeruginosa bloodstream infections: risk factors and mortality 35
A multicenter study of septic shock due to candidemia: outcomes and predictors of mortality 33
Direct MALDI-TOF Mass Spectrometry Assay of Blood Culture Broths for Rapid Identification of Candida Species Causing Bloodstream Infections: an Observational Study in Two Large Microbiology Laboratories 33
Use of Cefiderocol in Adult Patients: Descriptive Analysis from a Prospective, Multicenter, Cohort Study 33
Risk factors and mortality of healthcare-associated and community-acquired Staphylococcus aureus bacteraemia 33
New advances in management and treatment of multidrug-resistant Klebsiella pneumoniae 33
Excavated pulmonary lesions: differential diagnosis in a health-care worker 33
A multinational, preregistered cohort study of β-lactam/β-lactamase inhibitor combinations for treatment of bloodstream infections due to extended-spectrum-β-lactamase-producing enterobacteriaceae 32
Infections caused by KPC-producing Klebsiella pneumoniae: differences in therapy and mortality in a multicentre study 32
Antibiotic Treatment of Carbapenem-Resistant Acinetobacter baumannii Infections in View of the Newly Developed β-Lactams: A Narrative Review of the Existing Evidence 32
Effect of aerosolized colistin as adjunctive treatment on the outcomes of microbiologically documented ventilator-associated pneumonia caused by colistin-only susceptible Gram-negative bacteria 31
Clinical phenotypes and outcomes in children with multisystem inflammatory syndrome across SARS-CoV-2 variant eras: a multinational study from the 4CE consortium 31
Risk factors for hepatitis B and C among healthy population: a community-based survey from four districts of Southern Italy 30
Spike-specific T-cell responses in patients with COVID-19 successfully treated with neutralizing monoclonal antibodies against SARS-CoV-2 30
Tuberculosis and drug resistance in a region of Southern Italy among native and foreign-born populations: A twelve-year province-based study 30
Intravenous Fosfomycin: The Underdog Player in the Treatment of Carbapenem-resistant Acinetobacter baumannii Infections 30
Long-term kidney function recovery and mortality after COVID-19-associated acute kidney injury: An international multi-centre observational cohort study 30
Characterization of long COVID temporal sub-phenotypes by distributed representation learning from electronic health record data: a cohort study 30
Bloodstream infections in haematological cancer patients colonized by multidrug-resistant bacteria 30
Understanding cutaneous tuberculosis: two clinical cases 29
Analysis of the persistence time of the SARS-CoV-2 virus in the cadaver and the risk of passing infection to autopsy staff 29
Geographical variation in therapy for bloodstream infections due to multidrug-resistant Enterobacteriaceae: a post-hoc analysis of the INCREMENT study 29
Predictors of Mortality in Patients with Bloodstream Infections Caused by Extended-Spectrum-β-Lactamase-Producing Enterobacteriaceae: Importance of Inadequate Initial Antimicrobial Treatment 29
COVID-19-associated pulmonary aspergillosis in intensive care unit: A real-life experience 29
Early initiation of combined therapy in severely immunocompromised patients with COVID-19: a retrospective cohort study 29
Role of IgG and IgM and proinflammatory aspecific markers in the diagnosis and prognosis of COVID-19 patients stratified by number of positive SARS-CoV-2 genes 29
Superinfections caused by carbapenem-resistant Enterobacterales in hospitalized patients with COVID-19: a multicentre observational study from Italy (CREVID Study) 29
Lights and Shadows of Long COVID: Are Latent Infections the Real Hidden Enemy? 29
Antimicrobial-resistant Gram-negative bacteria in febrile neutropenic patients with cancer: current epidemiology and clinical impact 29
EFFICACY OF CEFIDEROCOL- VERSUS COLISTIN-CONTAINING REGIMEN FOR TREATMENT OF BACTEREMIC VENTILATOR-ASSOCIATED PNEUMONIA CAUSED BY CARBAPENEM-RESISTANT ACINETOBACTER BAUMANNII IN COVID-19 PATIENTS 28
Effect of directly acting antivirals for hepatitis C virus infection on proprotein convertase subtilisin/kexin type 9 level 28
Sex-Specific HLA Alleles Contribute to the Modulation of COVID-19 Severity 28
Utility, acceptability and applicability of a nucleic acid amplification test in comparison with a syndromic approach in the management of sexually transmitted diseases at Mulago National Referral Hospital in Uganda (ASTRHA): protocol for an open-label, randomised controlled trial 28
Effect of appropriate combination therapy on mortality of patients with bloodstream infections due to carbapenemase-producing Enterobacteriaceae (INCREMENT): a retrospective cohort study 28
Publisher Correction: Lessons learned and implications of early therapies for coronavirus disease in a territorial service centre in the Calabria region: a retrospective study 28
Effect of combination therapy containing a high-dose carbapenem on mortality in patients with carbapenem-resistant Klebsiella pneumoniae bloodstream infection 28
Bloodstream infections caused by Escherichia coli in onco-haematological patients: Risk factors and mortality in an Italian prospective survey 28
Clinical aspects and predictors of mortality of Pseudomonas aeruginosa pneumonia in a cohort of critically ill patients 28
A systematic review on antibiotic therapy of cutaneous bacillary angiomatosis not related to major immunocompromising conditions: from pathogenesis to treatment 28
Epidemiology, Species Distribution, Antifungal Susceptibility, and Outcome of Candidemia across five sites in Italy and Spain 28
Are we doing enough for controlling tuberculosis and multi-drug resistance in an epicenter of the current migration emergency (Calabria Region, Southern Italy)? 28
Persistence of SARS-CoV-2 infection and viral intra- and inter-host evolution in COVID-19 hospitalized patients 28
Ceftolozane/tazobactam for difficult-to-treat Pseudomonas aeruginosa infections: A systematic review of its efficacy and safety for off-label indications 27
Listeria infection after treatment with alemtuzumab: A case report and literature review. would antibiotic prophylaxis be considered? 27
Clinical Characteristics and Outcome of Hospitalized COVID-19 Patients Treated with Standard Dose of Dexamethasone or High Dose of Methylprednisolone 27
Weight of Clinical and Social Determinants of Metabolic Syndrome in People Living with HIV 27
Infezioni del cuore e del mediastino 27
A case report of pneumomediastinum in a COVID-19 patient treated with high-flow nasal cannula and review of the literature: Is this a “spontaneous” complication? 27
Common cardiovascular risk factors and in-hospital mortality in 3,894 patients with COVID-19: survival analysis and machine learning-based findings from the multicentre Italian CORIST Study 27
Predictors of mortality in multidrug-resistant Klebsiella pneumoniae bloodstream infections 27
The Spread of SARS-CoV-2 Omicron Variant in CALABRIA: A Spatio-Temporal Report of Viral Genome Evolution 26
Clinical features and comorbidity pattern of HCV infected migrants compared to native patients in care in Italy: A real-life evaluation of the PITER cohort 26
INTERLEUKIN-62/LYMPHOCYTE AS A PROPOSED PREDICTIVE INDEX FOR COVID-19 PATIENTS TREATED WITH MONOCLONAL ANTIBODIES 26
Characteristics, outcome and predictors of in-hospital mortality in an elderly population from a SARS-CoV-2 outbreak in a long-term care facility 26
Ertapenem for the treatment of bloodstream infections due to ESBL-producing Enterobacteriaceae: A multinational pre-registered cohort study 26
The Effect of Polymorphisms in Candidate Genes on the Long-Term Risk of Lipodystrophy and Dyslipidemia in HIV-Infected White Patients Starting Antiretroviral Therapy 26
Evaluation of the Practice of Antifungal Prophylaxis Use in Patients With Newly Diagnosed Acute Myeloid Leukemia: Results From the SEIFEM 2010-B Registry 26
EVALUATION OF IL-35, AS A POSSIBLE BIOMARKER FOR FOLLOW-UP AFTER THERAPY, IN CHRONIC HUMAN SCHISTOSOMA INFECTION 26
Pharmacokinetics of etravirine in HIV-infected patients concomitantly treated with rifampin for tuberculosis 26
Carbapenemase-producing Klebsiella pneumoniae and hematologic malignancies 26
Circulation of a Unique Klebsiella pneumoniae Clone, ST147 NDM-1/OXA-48, in Two Diverse Hospitals in Calabria (Italy) 26
Ceftazidime-avibactam use for klebsiella pneumoniae carbapenemase-producing k. pneumoniae infections: A retrospective observational multicenter study 26
Potential pitfalls in the use of real-world data for studying long COVID 26
Mortality in patients, with early-or late-onset candidaemia 26
Incidence, risk factors, and predictors of outcome of candidemia. Survey in 2 Italian university hospitals 26
Risk factors and outcomes of candidemia caused by biofilm-forming isolates in a tertiary care hospital 26
Reply to "Identifying Patients Harboring Extended-Spectrum-beta-Lactamase-Producing Enterobacteriaceae on Hospital Admission Is Not That Simple" 25
Disentangling the Association of Hydroxychloroquine Treatment with Mortality in Covid-19 Hospitalized Patients through Hierarchical Clustering 25
Factors associated with mortality in bacteremic patients with hematologic malignancies 25
International comparisons of laboratory values from the 4CE collaborative to predict COVID-19 mortality 25
Enzyme-Linked Immunospot Assay as a Complementary Method to Assess and Monitor Cytomegalovirus Infection in Kidney Transplant. Recipients on Pre-emptive Antiviral Therapy: A Single-Center Experience 25
MALATTIE DA RICKETTSIE 25
Acute respiratory distress syndrome after SARS-CoV-2 infection on young adult population: International observational federated study based on electronic health records through the 4CE consortium 25
EVALUATION OF IL-35, AS A POSSIBLE BIOMARKER FOR FOLLOW-UP AFTER THERAPY, IN CHRONIC HUMAN SCHISTOSOMA INFECTION 25
Cytokine Profile of Invasive Pulmonary Aspergillosis in Severe COVID-19 and Possible Therapeutic Targets 25
Insights into reasons for discontinuation according to year of starting first regimen of highly active antiretroviral therapy in a cohort of antiretroviral-naive patients 25
Lights and Shadows of Sepsis Management: Challenges and Future Perspectives 25
Efficacy and durability of two- vs. three-drug integrase inhibitor-based regimens in virologically suppressed HIV-infected patients: Data from real-life ODOACRE cohort 25
Touching Base with Some Mediterranean Diseases of Interest from Paradigmatic Cases at the “Magna Graecia” University Unit of Infectious Diseases: A Didascalic Review 25
Safety and Effectiveness of Transvenous Lead Extraction in Octogenarians 25
Predictors of Mortality in Bloodstream Infections Caused by Klebsiella pneumoniae Carbapenemase-Producing K. pneumoniae: Importance of Combination Therapy 25
Multicenter, prospective exploratory evaluation of quality of life in people living with HIV 25
The role of Gram-negative bacteria in skin and soft tissue infections 25
Spontaneous and severe haematomas in patients with COVID-19 on low-molecular-weight heparin for paroxysmal atrial fibrillation 24
Combined lymphocyte/monocyte count, D-dimer and iron status predict COVID-19 course and outcome in a long-term care facility 24
Tuberculosis and Drug Resistance in a Region of Southern Italy Among Native and Foreign-Born Populations: A Twelve-Year Province-Based Study 24
Considerations on antimicrobial prophylaxis in patients with lymphoproliferative diseases: A SEIFEM group position paper 24
Azole resistance of Candida glabrata in a case of recurrent fungemia 24
Pre-chemotherapy risk factors for invasive fungal diseases: prospective analysis of 1,192 patients with newly diagnosed acute myeloid leukemia (SEIFEM 2010-a multicenter study) 24
Apparent inefficacy of hydroxychloroquine combined with azithromycin on SARS-CoV-2 clearance in an incident cohort of geriatric patients with COVID-19 24
Totale 2.893
Categoria #
all - tutte 17.237
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 17.237


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2024/202520 0 0 0 0 0 0 0 0 0 0 0 20
2025/20264.689 754 119 875 1.380 426 62 147 377 238 311 0 0
Totale 4.709